Andrew Sims
Tracked across 1 events · 6 articles · First seen Sep 10, 2026 · Last active Sep 13, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Cerenome, Inc. (Nasdaq: CNSY), a clinical-stage CNS oncology company, announced on September 10, 2026 that it entered into a financing agreement with 3i, LP for a senior secured facility of up to $20 million with…
Impact: Andrew Sims, Cerenome's CFO, commented on the facility's minimally dilutive structure and the extended cash runway into 2028.
Sep 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Andrew Sims live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard